Table 6.
Future perspectives.
| OV-mediated gene therapy, incorporation of therapeutic genes |
| Improving tumor targeting of OVs by carrier cells |
| Improving T-cell costimulation by bi- or tri-specific antibodies |
| Improving OV targeting of immune cells by loading the cells with tri-specific antibodies |
| Combining OV therapy with checkpoint inhibitors |
| Combining OV therapy with physical modalities such as mEHT |
| Combining OV therapy with pharmacological modulation |